Alex Carchidi

Alex Carchidi

TMFacarchidi

Recent articles

GettyImages-1212883439

Could Investing in Vaxart Make You a Millionaire?

Thanks to its innovative vaccine technology platform and recently fast-tracked COVID-19 vaccine candidate, Vaxart is likely a millionaire-maker stock.


GettyImages-816222658

Better Buy: Eli Lilly vs. Johnson & Johnson

These two healthcare behemoths have something to offer most investors.


GettyImages-1215331788

Forget Vertex, Biogen Is a Better Value Stock

Biogen is more profitable, more innovative, and its stock may be undervalued to boot.


GettyImages-1189302646

Everything You Need To Know About Zocdoc

Helping doctors and patients find each other is an essential role in the U.S. healthcare system.


GettyImages-178533027

What Will the World for Nonprofits Look Like After COVID-19?

Sadly, many charities won’t make it out of the pandemic, but it's easy to predict which ones will.

GettyImages-1249249358

Better Coronavirus Stock: VBI Vaccines or Vaxart?

A company's vaccine manufacturing capabilities can make a world of difference.


GettyImages-1215061073

Smart Investors Might Consider Buying This Coronavirus Stock That Just Popped 96%

Vaxart’s aggressive moves to scale up its vaccine-manufacturing capabilities bode well for the company’s future.


GettyImages-800433994

Could Edwards Lifesciences Be a Millionaire-Maker Stock?

Strong revenue growth and low debt make this stock a winner.


GettyImages-1144631119

Everything You Need to Know About GoodRx

Could this drug couponing start-up be headed for IPO or is it a takeover target? Either way, it's helping consumers save billions at the pharmacy.


GettyImages-134168861

Better Buy: Invitae vs. Illumina

Illumina is practically an institution in the biotech sector, but can it outgrow an aggressive competitor?

GettyImages-1035004756

Is Sage Therapeutics a Buy?

With its recent clinical trial stumble and falling revenues for its only approved drug on the market, Sage may be in trouble.


GettyImages-1194078034

Everything You Need To Know About Teladoc

Based on its recent explosion of growth, Teladoc is making waves in telemedicine.


GettyImages-1185501448

Got $1,000? Here Are 3 Nonprofits Deserving of Your Money

Healthcare nonprofits are a great option for a charitable donation, and these three organizations are among the best.


GettyImages-1209968955

Everything You Need to Know About At-Home Testing Start-Ups 23andMe, Ancestry, and Everlywell

The direct-to-consumer health testing market is still nascent, but these companies are leading the way.


GettyImages-1158244843

3 Top Animal-Health Companies to Buy in June

With these three animal-health stocks, your portfolio will be stronger than ever.

GettyImages-1216432083

Better Coronavirus Stock: Grifols or Novartis?

Each company has a triad of COVID-19 projects, but they aren't in direct competition.


GettyImages-1146913659

Better Buy: Pfizer vs. Merck

Only one of these two pharma titans has a history of growth.


GettyImages-1215518076

Better Coronavirus Stock: Thermo Fisher Scientific or Roche?

Both companies have moved aggressively to produce diagnostic tests for COVID-19, and both are positioned for growth.


GettyImages-1213210484

Here’s How The COVID-19 Pandemic Has Affected Healthcare Professionals

The coronavirus crisis thrusts medical workers into the global spotlight, but many of their new struggles remain invisible.


GettyImages-532394887

So You Want To Be A Doctor? Take These 3 Steps First

Getting into medical school has never been more competitive, so it pays to do some preliminary research before setting your sights on a career as a doctor.